Next generation microfluidics technology for human and animal diagnostics KU Leuven
The Point of Care (POC) diagnostics market has witnessed intense growth over the last decade. Despite the advent of many innovative technologies, the POC market is still dominated by decades-old Lateral Flow Assay (LFA) technology. LFA enables integration of basic immunoassays on a cheap, disposable platform, but is limited in sensitivity and quantitative performance. As such, more demanding assays are confined to the lab. We have developed a ...